Sunitinib in combination with mFOLFOX6 chemotherapy in patients with advanced solid tumors: A phase I study

被引：0
|
作者：
Leong, S.
Eckhardt, S.
Chan, E.
Chow, L.
VerMeulen, W.
Camidge, D.
Rothenberg, M.
Chow Maneval, E.
Chao, R.
Lockhart, A.
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Vanderbilt Univ, Med Ctr, Knoxville, TN USA
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII123 / VII123
页数：1
相关论文
共 50 条
  • [1] A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors
    McRee, Autumn J.
    Davies, Janine M.
    Sanoff, Hanna G.
    Goldberg, Richard M.
    Bernard, Stephen
    Dees, E. Claire
    Keller, Kimberly
    Ivanova, Anastasia
    O'Neil, Bert H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 117 - 123
  • [2] A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors
    Autumn J. McRee
    Janine M. Davies
    Hanna G. Sanoff
    Richard M. Goldberg
    Stephen Bernard
    E. Claire Dees
    Kimberly Keller
    Anastasia Ivanova
    Bert H. O’Neil
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 117 - 123
  • [3] A phase I study of bevacizumab in combination with sunitinib in advanced solid tumors
    Cooney, M. M.
    Garcia, J.
    Brell, J.
    Dreicer, R.
    Beatty, K.
    Mekhail, T.
    Bukowski, R.
    Zwiebel, J.
    Remick, S. C.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] A phase I trial of imatinib in combination with mFOLFOX6–bevacizumab in patients with advanced colorectal cancer
    M. Michael
    J. Zalcberg
    P. Gibbs
    L. Lipton
    M. Gouillou
    M. Jefford
    G. McArthur
    M. Copeman
    K. Lynch
    N. C. Tebbutt
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 321 - 330
  • [5] A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer.
    Shanda, Safi
    Noonan, Anne M.
    Bekaii-Saab, Tanios S.
    O'Neil, Bert H.
    Sehdev, Amikar
    Shaib, Walid Labib
    Helft, Paul R.
    Loehrer, Patrick J.
    Tong, Yan
    Liu, Ziyue
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Sunitinib combined with modified (m) FOLFCX6 chemotherapy in patients with advanced solid tumors: a phase I study
    Leong, S.
    Eckhardt, S. G.
    Chan, E.
    Chow, L. Q.
    VerMeulen, W.
    Rothenberg, M. L.
    Bello, A.
    Maneval, E. Chow
    Chao, R.
    Lockhart, A. C.
    EJC SUPPLEMENTS, 2007, 5 (04): : 112 - 112
  • [7] Sunitinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors: Updated phase I study results
    Heath, E. I.
    Blumenschein, G. R., Jr.
    Cohen, R. B.
    LoRusso, P. M.
    LoConte, N.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer
    Michael, Michael
    Gibbs, Peter
    Smith, Robert
    Godwood, Alex
    Oliver, Stuart
    Tebbutt, Niall
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (03) : 253 - 261
  • [9] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Elisabeth I. Heath
    George R. Blumenschein
    Roger B. Cohen
    Patricia M. LoRusso
    Noelle K. LoConte
    Sindy T. Kim
    Ana Ruiz-Garcia
    Richard C. Chao
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 703 - 712
  • [10] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
12345